ArticleOncotarget2021

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma.

Arvin Medhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.